Clinical Trial Update: A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the effect on lung function of a BDA formulation with a next-generation propellant versus an approved asthma treatment in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BDA with HFA Propellant

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: ACTIVE_NOT_RECRUITING